In Vitro Anticancer Activity of Nanoformulated Mono- and Di-nuclear Pt Compounds

Pan Wang, Jian Wei Wang, Wen Hua Zhang, Hongzhen Bai, Guping Tang, David J. Young

    Research output: Contribution to journalArticlepeer-review


    Nanoformulations of mononuclear Pt complexes cis-PtCl2(PPh3)2 (1), [Pt(PPh3)2(L−Cys)] ⋅ H2O (3, L−Cys=L-cysteinate), trans-PtCl2(PPh2PhNMe2)2 (4; PPh2PhNMe2=4-(dimethylamine)triphenylphosphine), trans-PtI2(PPh2PhNMe2)2 (5) and dinuclear Pt cluster Pt2(μ-S)2(PPh3)4 (2) have comparable cytotoxicity to cisplatin against murine melanoma cell line B16F10. Masking of these discrete molecular entities within the hydrophobic core of Pluronic® F-127 significantly boosted their solubility and stability, ensuring efficient cellular uptake, giving in vitro IC50 values in the range of 0.87–11.23 μM. These results highlight the potential therapeutic value of Pt complexes featuring stable Pt−P bonds in nanocomposite formulations with biocompatible amphiphilic polymers.

    Original languageEnglish
    Pages (from-to)2993-3000
    Number of pages8
    JournalChemistry - An Asian Journal
    Issue number19
    Early online date12 Aug 2021
    Publication statusPublished - Oct 2021


    Dive into the research topics of 'In Vitro Anticancer Activity of Nanoformulated Mono- and Di-nuclear Pt Compounds'. Together they form a unique fingerprint.

    Cite this